Noninvasive Thymoma and Thymic Carcinoma
Invasive Thymoma and Thymic Carcinoma
Recurrent Thymoma and Thymic Carcinoma

Noninvasive Thymoma and Thymic Carcinoma

Treatment of noninvasive thymoma and thymic carcinoma may include the following:

• Surgery to remove the tumor.
• Radiation therapy.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with noninvasive thymoma and thymic carcinoma.

Treatment of invasive thymoma and thymic carcinoma that may be completely removed by surgery includes the following:

• Surgery followed by radiation therapy.
• A clinical trial of other new treatments.

Treatment of invasive thymoma and thymic carcinoma that cannot be removed completely by surgery includes the following:

• Surgery to remove part of the tumor, followed by radiation therapy with or without chemotherapy.
• A clinical trial of chemotherapy using one or more anticancer drugs.
• A clinical trial of chemotherapy before surgery, with or without radiation therapy.
• A clinical trial of combination chemotherapy followed by radiation therapy.
• A clinical trial of other new treatments.

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with invasive thymoma and thymic carcinoma.

Treatment of recurrent thymoma and thymic carcinoma may include the following:

• Surgery with or without radiation therapy.
• Radiation therapy.
• Hormone therapy.
• A clinical trial of chemotherapy using one or more anticancer drugs.
• A clinical trial of other new treatments.

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent thymoma and thymic carcinoma.

Back to Top

< Previous Section  |  Next Section >